LOGIN
AAOS 2023: Single-Shot Liposomal Bupivacaine vs. Continuous Catheter Block in Rotator Cuff Repair
March 2023
AAOS 2023: Single-Shot Liposomal Bupivacaine vs. Continuous Catheter Block in Rotator Cuff Repair
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Single-Shot Liposomal Bupivacaine Interscalene Nerve Block Provides Equivalent Pain Relief Compared to Continuous Catheter Interscalene Nerve Block for Arthroscopic Rotator Cuff Repair
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
90 patients undergoing arthroscopic rotator cuff repair were randomized to receive a single-shot liposomal bupivacaine interscalene block (n=45) or standard bupivacaine interscalene block via a continuous catheter (n=45). The primary outcome of interest was pain scores on a Visual Analog Scale (VAS). Secondary outcomes of interest included block related complications, patient satisfaction, anesthe...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.